Close
Digital Health & Ai Innovation summit 2026
APE 2026

Industry Updates

BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

BD , a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care...

optimize.health releases free SMS-based survey to aid healthcare workers in their battle against COVID-19

optimize.health, the digital healthcare platform that powers provider reimbursements for the new wave of remote patient care, today announced the release of a new COVID-19 screening survey...

AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved for use in Europe as medical device

AI-Pathway Companion Prostate Cancer, a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical...

FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings

Siemens Healthineers announced that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug...

$2M Grant Will Galvanize COVID-19 Response at Zuckerberg San Francisco General Hospital

To help combat the public health crisis presented by the COVID-19 pandemic, the Heising-Simons Foundation has made a $2 million grant to UC San Francisco...

GE Announces Completion of BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds

GE Chairman and CEO H. Lawrence Culp, Jr., said, “Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable...

Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus

Covalon Technologies Ltd. , an advanced medical technologies company, announces  its new breakthrough antimicrobial technology formulated to kill the COVID-19 virus (or “SARS-CoV-2”) and other...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »